688658.SH
悦康药业
SSE · Healthcare · Biotechnology · CN
CNY 13.21
−7.69%Margins
Gross margin
53.0%
EBITDA margin
-1.2%
EBIT margin
-8.5%
Net margin
-10.2%
FCF margin
8.3%
-7.5%
Return on equity
-4.7%
Return on assets
-5.4%
Return on invested capital
0.47x
Asset turnover
CNY 303.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026